Literature DB >> 8605730

IL-4 and TNF-alpha induce changes in integrin expression and adhesive properties and decrease the lung-colonizing potential of HT-29 colon carcinoma cells.

F Herzberg1, M Schöning, M Schirner, M Topp, E Thiel, E D Kreuser.   

Abstract

The colon carcinoma cell line HT-29 was used to explore the potential of interleukin-4 (IL-4) and tumor necrosis factor alpha (TNF-alpha) to modify integrin expression and adhesive functions of tumor cells in vitro and to examine corresponding metastatic effects in vivo. Preincubation of HT-29 cells with 100 U/ml of IL-4 for 48 h downregulated the surface expression of the integrin subunits alpha 2, alpha 3, beta 1 and beta 4 after 48 h, whereas the alpha 1 subunit was upregulated. In contrast, 100 U/ml to TNF-alpha selectively upmodulated the expression of alpha v. Attachment to fibronectin of cells treated with IL-4 increased twofold (63.5% vs 32.4%). Adhesion to fibronectin (54.0% vs 32.4%) and vitronectin (37.9% vs 16.4%) was elevated in the case of TNF-alpha stimulation. Using an experimental metastasis model, HT-29 cells showed a significant reduction of their lung-colonizing potential in nude mice when preincubated with IL-4 for 48 h before intravenous injection. The decrease also observed for TNF-alpha-treated cells was less pronounced. The data indicate that the cytokines IL-4 and TNF-alpha can act as direct regulators of adhesive mechanisms of tumor cells bearing adequate receptors, thus influencing lung-colony formation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605730     DOI: 10.1007/bf00121213

Source DB:  PubMed          Journal:  Clin Exp Metastasis        ISSN: 0262-0898            Impact factor:   5.150


  44 in total

1.  Self-association of the "death domains" of the p55 tumor necrosis factor (TNF) receptor and Fas/APO1 prompts signaling for TNF and Fas/APO1 effects.

Authors:  M P Boldin; I L Mett; E E Varfolomeev; I Chumakov; Y Shemer-Avni; J H Camonis; D Wallach
Journal:  J Biol Chem       Date:  1995-01-06       Impact factor: 5.157

2.  A monoclonal antibody inhibits adhesion to fibronectin and vitronectin of a colon carcinoma cell line and recognizes the integrins alpha v beta 3, alpha v beta 5, and alpha v beta 6.

Authors:  M Lehmann; C Rabenandrasana; R Tamura; J C Lissitzky; V Quaranta; J Pichon; J Marvaldi
Journal:  Cancer Res       Date:  1994-04-15       Impact factor: 12.701

3.  Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.

Authors:  F G Giancotti; E Ruoslahti
Journal:  Cell       Date:  1990-03-09       Impact factor: 41.582

4.  Co-ordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer.

Authors:  A J D'Ardenne; P I Richman; M A Horton; A E Mcaulay; S Jordan
Journal:  J Pathol       Date:  1991-11       Impact factor: 7.996

5.  Selective up-regulation of human granulocyte integrins and complement receptor 1 by cytokines.

Authors:  G A Limb; A S Hamblin; R A Wolstencroft; D C Dumonde
Journal:  Immunology       Date:  1991-12       Impact factor: 7.397

6.  Tumour invasion: effects of cell adhesion and motility.

Authors:  F Van Roy; M Mareel
Journal:  Trends Cell Biol       Date:  1992-06       Impact factor: 20.808

7.  Effect of interleukin-1-beta on metastasis formation in different tumor systems.

Authors:  M R Bani; A Garofalo; E Scanziani; R Giavazzi
Journal:  J Natl Cancer Inst       Date:  1991-01-16       Impact factor: 13.506

8.  Regulation of cell adhesion receptors by transforming growth factor-beta. Concomitant regulation of integrins that share a common beta 1 subunit.

Authors:  J Heino; R A Ignotz; M E Hemler; C Crouse; J Massagué
Journal:  J Biol Chem       Date:  1989-01-05       Impact factor: 5.157

9.  Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies.

Authors:  M S Topp; C A Papadimitriou; F Eitelbach; M Koenigsmann; E Oelmann; B Koehler; D Oberberg; B Reufi; H Stein; E Thiel
Journal:  Cancer Res       Date:  1995-05-15       Impact factor: 12.701

10.  Interleukin-4 receptor and epidermal growth factor receptor expression in colorectal cancer.

Authors:  L Kaklamanis; K C Gatter; N Mortensen; A L Harris
Journal:  Br J Cancer       Date:  1992-10       Impact factor: 7.640

View more
  7 in total

1.  Hypomethylation of the metastasis-associated S100A4 gene correlates with gene activation in human colon adenocarcinoma cell lines.

Authors:  N Nakamura; K Takenaga
Journal:  Clin Exp Metastasis       Date:  1998-07       Impact factor: 5.150

2.  Expression and functional activity of the very late activation antigen-4 molecule on human natural killer cells in different states of activation.

Authors:  C Macías; J M Ballester; P Hernández
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

3.  Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

4.  Systematic analysis of tumour cell-extracellular matrix adhesion identifies independent prognostic factors in breast cancer.

Authors:  Jason R Todd; Karen A Ryall; Simon Vyse; Jocelyn P Wong; Rachael C Natrajan; Yinyin Yuan; Aik-Choon Tan; Paul H Huang
Journal:  Oncotarget       Date:  2016-09-27

Review 5.  Possible Roles of Interleukin-4 and -13 and Their Receptors in Gastric and Colon Cancer.

Authors:  Xujun Song; Benno Traub; Jingwei Shi; Marko Kornmann
Journal:  Int J Mol Sci       Date:  2021-01-13       Impact factor: 5.923

Review 6.  Thy-1 (CD90), Integrins and Syndecan 4 are Key Regulators of Skin Wound Healing.

Authors:  Leonardo A Pérez; Lisette Leyton; Alejandra Valdivia
Journal:  Front Cell Dev Biol       Date:  2022-02-03

Review 7.  Cytokine determinants of viral tropism.

Authors:  Grant McFadden; Mohamed R Mohamed; Masmudur M Rahman; Eric Bartee
Journal:  Nat Rev Immunol       Date:  2009-08-21       Impact factor: 53.106

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.